Court Overturns $482M Patent Decision Against J&J

Friday, Apr 5, 2013  |  Updated 8:38 AM EDT
View Comments (
)
|
Email
|
Print
Court Overturns $482M Patent Decision Against J&J

Getty Images/Tetra images RF

Stock image.

advertisement

A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.

The three-judge panel said a lower court misinterpreted the company's patent and should not have ruled in favor of Bruce Saffran, a doctor from Princeton, N.J.

Heart stents are mesh-wire tubes that prop open arteries affected by coronary artery disease. The dispute centered over drug-eluting stents, which release a drug to help keep arteries from clogging.

Saffran sued J&J in 2007 saying its Cypher stents infringed on his 1997 patent covering technology to deliver medication inside the body. A Texas jury ruled in Saffran's favor in 2011, concluding J&J had willfully infringed on his patent.

RELATED STORIES:

 


Get the latest from NBC10 Philadelphia anytime: Android/iPhone/iPad Apps | SMS Alerts | Twitter | Facebook | Google+ | Instagram | RSS

Get the latest headlines sent to your inbox!
View Comments (
)
|
Email
|
Print
Leave Comments
What's New
FlyeredUp: Win 2 Tickets to Flyers Playoff Game
Win two tickets to the first... Read more
Follow Us
Sign up to receive news and updates that matter to you.
Send Us Your Story Tips
Check Out